Discontinued — last reported Q4 '25
Cash, Cash Equivalents, and Marketable Securities
Biogen Cash, Cash Equivalents, and Marketable Securities increased by 10.2% to $1.37B in Q1 2026 compared to the prior quarter. Over 3 years (FY 2020 to FY 2025), Cash, Cash Equivalents, and Marketable Securities shows a downward trend with a -15.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Higher levels provide a larger buffer for operational needs and strategic opportunities, while lower levels may indicate tight liquidity or aggressive capital deployment.
Detailed definition
This is the aggregate of all highly liquid assets, including cash, bank deposits, and short-term marketable securities t...
Peer comparison
A fundamental liquidity metric used by all public companies to assess financial health.
cash_equivalents_marketable_securities_totalHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.22B | $2.38B | $2.43B | $3.00B | $3.25B | $2.10B | $2.18B | $3.12B | $4.67B | $97.60M | $1.24B | $1.37B |
| QoQ Change | — | +7.1% | +2.2% | +23.5% | +8.3% | -35.6% | +4.0% | +43.2% | +49.6% | -97.9% | >999% | +10.2% |
| YoY Change | — | — | — | — | +46.3% | -12.0% | -10.4% | +3.9% | +43.5% | — | — | — |
Cash, Cash Equivalents, and Marketable Securities at Other Companies
Frequently Asked Questions
- What is Biogen's cash, cash equivalents, and marketable securities?
- Biogen (BIIB) reported cash, cash equivalents, and marketable securities of $1.37B in Q1 2026.
- What is the long-term trend for Biogen's cash, cash equivalents, and marketable securities?
- Over 3 years (2020 to 2025), Biogen's cash, cash equivalents, and marketable securities has grown at a -15.5% compound annual growth rate (CAGR), from $2.05B to $1.24B.
- What does cash, cash equivalents, and marketable securities mean?
- The total amount of cash and easily sellable investments the company holds.